Crest Ventures

Covered by Minerva Capital Research SolutionsNSE: CRESTBSE: 511413
Compare with peers
₹ 347.10▼ 3.55 (−1.01%)28 Oct, 03:29 pm IST
Market cap
₹ 956 Cr.
P/E
29.3x
P/B
0.76x
52-week range
298.15 – 418
ROE
4%
Dividend yield
0.3%
Debt / equity
0.16
Sector
Finance
Industry
Non Banking Financial Company (NBFC)
Listed on
NSE, BSE
Our research
1 report · call 19 Nov 2025
Buy

About

Crest Ventures Limited is an India-based Non-Banking Financial Company (NBFC). The Company is engaged in the business of real estate and related services, financial services and investment, and credit. The Company's segments include Investing & Financial Activities, Broking & Related Activities, and Real Estate & Related Activities. Investing & Financial Activities includes investing in subsidiaries, associates, joint ventures, and other entities, dealing in the fixed income securities market and advancing of inter corporate loans. Broking & Related Activities includes broking and related intermediary services in the wholesale debt market, foreign exchange markets, options and swaps, mutual fund, and portfolio management services. Real Estate & Related Activities includes sales of residential and commercial premises, project development fees and revenue from license fees and other services charged from its residential and commercial properties.

Quick check

The five things to look at first. Open one for more.

Crest Ventures against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)29.3 against a typical 22.5: pricier than most peers (1st = cheapest).159th of 284
  • Sales growth−52.4% against a typical +18.3% from a year earlier.233rd of 259
  • Profit growth−57.7% against a typical +20.2% from a year earlier.179th of 214
  • Share price, 3 months−6% against a typical −4.5%.144th of 258
  • Size₹ 955.9 Cr. market value against a typical ₹ 43 Cr. (1st = largest).35th of 269

Credit ratings

Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates

Moderate safety, with caution

Rated BBB by CARE
BBB
DefaultRiskyModerateSafeVery safe
  • No warnings from the agency.
AgencyCurrent ratingOutlookAs of
CARECARE BBBStable11 Dec 2025
Credit rating actions
RatingDetails
11 Dec 2025
Reaffirmed
CARE BBB—CARE₹ 300 Cr.

Research by Minerva Capital Research Solutions

Our research team's work on Crest Ventures

Our calls

Our calls on this company
19 Nov 2025Buy₹ 364.00−4.64%Open

Reports

Company note · 19 Nov 2025 · Free
Our view
Buy
Price at our call
₹ 364.00
Target
₹ 442.00
Since our call
−4.64%
Status
Open
Market cap then
INR 1,035 Cr.

Crest Ventures Ltd. develops real estate and provides financial services and credit. The analysis values its ongoing and announced-start projects alongside financial investments and loans, indicating a derived NPV of INR 1,722 Cr. and potential base-case upside of ~67%; the note does not state a formal recommendation or target price.

About Crest Ventures

Crest Ventures Ltd. was incorporated in 1982 and develops real estate, with a track record of delivering projects covering over 10 million sq.ft. across India. Its business has two verticals: real estate and financial services/credit. The company is registered with the RBI as a non-deposit-taking NBFC and is listed on NSE and BSE. It has developed projects through partnerships with groups including Kalpataru and Phoenix Mills Ltd.

Investment Rationale

  • Real estate and capital provision: Crest combines project capital provision with development activities, including design, planning and execution by its in-house team. The report describes this as a model combining developer agility with institutional financial discipline.
  • Partnership-led, asset-light approach: Projects use JDAs and partnerships with structures such as revenue sharing, variable economic interests and PMC contracts. The report says this keeps capital at risk low and supports scalable expansion.
  • Project selection and monitoring: The company selects projects in premium localities with clear demand and attractive risk-adjusted returns, then monitors each project on a standalone basis.
  • Experienced leadership: Promoter and Managing Director Mr. Vijay Choraria has over 30 years’ experience in real estate and the financial sector.
  • Completed project record: Completed work includes commercial, residential, redevelopment and township projects. In partnership with Phoenix Mills, CVL has built Phoenix MarketCity Lucknow, Bangalore and Pune.

Project Pipeline

The report lists ongoing projects in Mumbai, Jaipur and Raipur with cumulative GDV of INR 1,185 Cr. These include Crest 4 Pali Hill, Crest Oaks, Crest Uno, Project Hospital, Crest Park and Crest Greens Phase 2&3, with expected completion dates ranging from Q3 FY26 to Q2 FY29.

Upcoming projects in Mumbai and Raipur are listed with cumulative GDV of INR 8,210 Cr.+. Four projects with announced start dates—Crest Pantheon (Legacy), Crest Aspen, Project Saidale and Crest Golfshire—are included in the NPV computation. Project Lotus, Project Lalbaug and Project Central are excluded from the base case because their start dates are yet to be announced; the report identifies them as potential upside.

As of 30-Sep’25, the financial investments and loans summary lists investments at market value of 201.22, cash and cash equivalents of 78.97, ICDs and loans given of 325.07, properties at book value of 63.68, associates at book value of 121.38 and debt of (226.12), all in INR Cr. The reported total is 564.2.

Crest Ventures Key Financials

Historical Profit and Loss (INR Cr.)
ParticularsFY22FY23FY24FY25
Operating Revenues56.9650.5183.6204.3
EBITDA(17.3)568.985.4116.6
PAT12.1395.962.190.2

The historical table shows FY25 operating revenues of 204.3 and PAT of 90.2, compared with 183.6 and 62.1 respectively in FY24.

Valuation and Target Price

The valuation uses NPV of project cash flows and capital returns for ongoing projects and upcoming projects with announced start dates. Real estate assets are discounted at 13.5%, cash flows are considered at project completion, and the period considered is FY26 to FY30. Financial investments and loans are adjusted for real estate assets held by associates and financial liabilities are reduced. The resulting derived NPV is INR 1,722 Cr., against a current market cap of INR 1,035 Cr., with potential upside (base case) of ~67%. The report does not give a formal recommendation or a per-share target price.

INR 364/-
CMP (20-Nov’25)
INR 1,722 Cr.
Derived NPV
~67%
Potential upside (Base Case)

The base case excludes potential upside of ~INR 200 Cr. to 250 Cr. from multiple upcoming projects for which start dates are yet to be announced.

Key Risks

  • Real estate market exposure: The sector is linked to the macroeconomic environment, interest rates and disposable income. A slowdown in sales or lower realizations in Mumbai is identified as a key risk.
  • ICD repayment and liquidity: Liquidity depends on property markets, which do not provide stable revenue generation; this creates a risk of non-repayment of ICDs.
  • Volatile income: Income from management fees, lending, real estate and related activities is exposed to market vulnerabilities. Income stability also depends on subsidiary performance and opportunities to liquidate investments.
  • Unsecured lending: The company extends ICDs, including unsecured lending to group and non-group companies. The report says ICDs to non-group companies are usually given to entities known to the promoters.

Management

The company is led by promoter and Managing Director Mr. Vijay Choraria, who has over 30 years’ experience in real estate and the financial sector. The report describes the core team as including a CEO, COO and Project Director, and notes partnerships with architects, planners, construction firms and marketing teams.

Our View

The valuation case combines project NPV with the value of financial investments and loans less debt, and indicates potential base-case upside of ~67%. The report also identifies Mumbai real estate demand, ICD repayment and volatility in lending and investment returns as key risks. It does not state a formal recommendation or target price.

Standard disclosures

  • Research Analyst has served as an officer, director or employee of subject company(ies): No
  • We or our associates have received compensation from the subject company(ies) in the past 12 months: No
  • We or our associates have managed or co-managed public offering of securities for the subject company(ies) in the past12 months: No
  • We or our associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company(ies) in the past 12 months –No
  • We or our associates may have received compensation or other benefits from the subject company(ies) or third party in connection with the research report –No
  • We or our associates or Research Analyst or his/her relative's financial interest in the subject company(ies)- No
  • Nature of financial interest in subject company, if any –Nil
  • We, our associates or Research Analyst have actual/beneficial ownership of 1% or more securities of the subject company (ies) at the end of the month immediately preceding the date of publication of Research Report – No
  • Subject company (ies) may have been client during twelve months preceding the date of distribution of the research report-No.
  • We or our Associates or Research Analyst are engaged in market making of subject company – No
  • By referring to any particular sector, Minerva Capital Research Solutions does not provide any promise or assurance of favorable view for a particular industry or sector or business group in any manner. The investor is requested to take into consideration all the risk factors including their financial condition, suitability to risk return profile and take professional advice before investing. Such representations are not indicative of future results.
  • There are either no material conflict of interests or all existing and potential conflict of interest are disclosed herein.

Regulatory disclosures

Minerva Capital Research Solutions is an independent investment advisory firm founded by Nishant Gupta(SEBI registration no. INH000018896).

Registration granted by SEBI and certification from NISM in no way promise or guarantee that the research recommendation will provide any assured, minimum or risk-free return to the investors.

The research report serves as general information and does not account for individual investment goals, financial situations, or needs. Minerva Capital Research Solutions strives to provide reliable and comprehensive information, sourced from what are believed to be trustworthy channels. However, this information has not been independently verified by Minerva Capital Research Solutions or its analysts, and no guarantees are made regarding its accuracy or completeness. The opinions expressed in this report reflect the views of the research analyst at the time of publication and may change over time. Minerva Capital Research Solutions and its affiliates as on date of publication of this report may or may not hold any positions in the securities discussed. The views presented are general and do not consider individual risk tolerance or investment objectives; therefore, readers should seek independent professional advice before making investment decisions. Minerva Capital Research Solutions does not guarantee a favorable outlook for any specific industry or sector and urges investors to consider all relevant risk factors, including their financial circumstances, before investing. The analyst certifies that their views accurately represent their personal opinions on the companies discussed and that no part of their compensation is tied to specific recommendations made in this report. This material should not be interpreted as an offer or solicitation to buy or sell securities in jurisdictions where such offers would be illegal. Consequently, brokerage and investment services described herein are not available to Canadian or U.S. persons. Distribution outside India requires prior written consent. This Research Report assumes that the recipient will assume all risks associated with its contents. If there are any disagreements or dissatisfaction with this report or its disclaimer, the only recourse is to cease using it. Minerva Capital Research Solutions and its affiliates will not be liable for any direct or indirect losses resulting from the use of this report. Recipients are required to adhere to these restrictions. The material is for the personal use of authorized individuals and does not constitute a solicitation or offer to buy or sell any securities in jurisdictions where such actions would be illegal.

For any queries or grievances: Mr. Nishant Gupta | Email: nishant.gupta@mcapital.in or guptanishant.iimi@gmail.com| Contact Number: 8171433387 | Website: www.mcapital.in | Twitter: @Mcapital_In

Rating rationale

Minerva Capital Research Solutions endeavors to provide objective opinions and recommendations. Ratings are assigned to stocks according to their fair value vs current market price and then categorizes them as Buy, Hold, Reduce, Sell. The performance horizon is one year unless specified and fair value is defined as analyst’s valuation for a stock.

  • Buy:> 15%
  • Hold: -5% to 15%
  • Reduce: -15% to -5%
  • Sell: <-15%

Board meetings

Results dates and other board meetings. Full calendar

Details
13 Aug 2026Financial ResultsTo consider and approve the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026.
22 May 2026Financial Results/Dividenda) To consider and approve Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026; b) To consider and recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2026.
13 Feb 2026Financial ResultsTo consider and approve the Un-Audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025.
12 Dec 2025Fund RaisingDebenture Fund Raising Committee Meeting Intimation - Approval of Terms of Issuance for Non- Convertible Debentures (NCDs)
14 Nov 2025Financial Results/Fund RaisingCREST : 14-Nov-2025 : The Company has informed the Exchange that the Board meeting scheduled to be held on November 11, 2025 has been re-scheduled to November 14, 2025, to consider and approve a. the Audited Standalone Financial Results and Un-audited Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2025;b. raising of funds, including but not limited to, Qualified Institutions Placement of permissible securities and issuance of Redeemable Non-Convertible Debentures, subject to such regulatory/statutory approvals as may be required.
11 Nov 2025Financial ResultsTo consider and approve the Audited Standalone Financial Results and Unaudited Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2025.

Share price

1Y change −12.06%
Volume (shares)Price (₹)
Close priceOur calls (1)

Financials

Consolidated figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue615240773544486330353230
Interest666655545555
Expenses142918101020302318161515
Financing Profit41171662211912367131110
Financing Margin %68%32%40%80%58%43%26%57%23%39%36%33%
Other Income000011000116
Depreciation111111111221
Profit before tax40151561201911356131114
Tax %21%28%26%17%12%24%31%27%33%25%23%19%
Net Profit321212501815826410911
EPS in Rs11.314.324.1317.316.025.062.728.851.313.372.933.99

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
13%
5 Years
24%
3 Years
−37%
TTM
−34%
Compounded Profit Growth
10 Years
2%
5 Years
73%
3 Years
−51%
TTM
−49%
Stock Price CAGR
10 Years
20%
5 Years
25%
3 Years
15%
TTM
—
Return on Equity
10 Years
12%
5 Years
13%
3 Years
6%
TTM
—

Shareholding

Latest: Jun 2026.

Promoters
69.84%
+0.09 pts in a year
FIIs
1.71%
+0.08 pts in a year
Public
27.81%
+0.07 pts in a year
Others
0.64%
−0.25 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 29.3xEPS (12 months) ₹ 11.60Median P/E 12.9x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Crest Ventures₹ 347.10₹ 956 Cr.29.3x0.8x4%—
ICICI Prudential Asset Management Company Ltd₹ 2,655.00₹ 1,30,928 Cr.47.7x37.7x—56%
HDFC Asset Management Company₹ 2,250.00₹ 96,542 Cr.39.9x12.3x—69.3%
Nippon Life India Asset Management₹ 922.10₹ 59,010 Cr.50.1x16.3x34.5%56.4%
Multi Commodity Exchange Of India₹ 3,017.00₹ 76,931 Cr.52.6x16.6x37.9%57.8%
Motilal Oswal Financial Services₹ 925.00₹ 55,715 Cr.30.8x4.5x15.6%21.2%

Management

Radhika Bhakuni
Chief Financial Officer
Namita Bapna
Compliance Officer, Company Secretary
Vijay Choraria
Managing Director, Executive Director

Prices are delayed and for information only. Nothing on this page is investment advice.